hemospray

05/01/2021 - "Hemospray is highly effective in achieving immediate hemostasis in gastrointestinal bleeding. "
01/01/2018 - "A Hemospray first approach is most cost-effective for nonulcer bleeding lesions at low risk of delayed hemorrhage."
04/01/2011 - "Use of Hemospray, where a nanopowder with clotting abilities is sprayed onto the bleeding site, had been highly effective for management of arterial bleeding in a heparizined animal model. "
04/01/2011 - "TC-325 is safe and highly effective in achieving hemostasis in an anticoagulated severe arterial gastrointestinal bleeding animal model."
04/01/2020 - "The bleeding was treated successfully with Hemospray."

01/01/2022 - "In this prospective, multicenter, single-arm study, patients with Forrest Ia or Ib peptic ulcers underwent endoscopic application of Hemospray as treatment of first intent. "
04/01/2011 - "Hemospray was effective in achieving acute hemostasis in active peptic ulcer bleeding."
02/01/2014 - "Hemospray has been shown to be safe and effective in achieving haemostasis in bleeding peptic ulcers in a prospective clinical study and several further case series have described the use of hemospray in other non-variceal causes of gastrointestinal bleeding. "
01/01/2022 - "Hemospray is an effective initial treatment for patients with active peptic ulcer bleeding, but care should be taken to monitor for recurrent bleeding. "
06/01/2017 - "Our pilot study aimed to compare the efficacy and safety of TC-325 with those of CCT in treating peptic ulcers with active bleeding or high-risk stigmata. "

11/01/2021 - "Hemospray achieved high rates of immediate hemostasis, with comparable rebleed rates following treatment of tumor-related upper gastrointestinal bleeds. "
06/09/2020 - "Hemospray (Cook Medical, Winston-Salem, NC, USA) is a recently approved modality and can help treat tumor-related GIB. "
01/01/2020 - "Role of TC-325 in GI tumor hemostasis."
05/01/2019 - "Long-Term Effectiveness, Safety and Mortality Associated with the Use of TC-325 for Malignancy-Related Upper Gastrointestinal Bleeds: A Multicentre Retrospective Study."
11/01/2021 - "The aim of this study was to examine the outcomes of upper gastrointestinal bleeds secondary to tumors treated with Hemospray therapy. "

11/01/2014 - "Aim of this study is to review the efficacy of traditional endoscopic treatment in Forrest 1a-1b ulcers and to investigate the usefulness of Hemospray in these patients. "
01/01/2021 - "After 7 days the sizes of the ulcers decreased significantly (stomach: - 22.8% with Hemospray application, - 19% without Hemospray application; rectum: - 50.8% with Hemospray application, - 49.5% without Hemospray application; p = 0.005-0.037), but without significant difference between both groups. "
01/01/2021 - "A prospective animal model was performed to evaluate the effect of Hemospray application on the healing process of artificially induced ulcers of the upper and lower gastrointestinal tract. "
01/01/2021 - "Healing of gastrointestinal ulcers after Hemospray application was reported in literature. "
06/01/2017 - "In patients with Forrest IIA or IIB ulcers, five received TC-325 monotherapy; none had rebleeding. "

08/01/2016 - "The study aims to assess the effectiveness of Hemospray (Cook Medical) in a swine model of post-endoscopic esophageal stricture. "
08/01/2016 - "Median esophageal diameter was greater in the group treated with Hemospray (2 mm [1-3] vs. 3 mm [2-4], P = 0.01), and the rate of symptomatic esophageal stricture was 100% and 60% in Groups 1 and 2, respectively (P = 0.09). "
08/01/2016 - "The application of Hemospray after esophageal CESD reduces scar tissue formation and promotes reepithelialization, and therefore is a promising therapeutic approach in the prevention of post-endoscopic esophageal stricture. "